RSSCategory: Business

Looking Back, Looking Forward

| August 2, 2017 | 0 Comments

On June 22, 2007 I wrote my first post on this blog. Over 3,100 posts later, a lot has changed. That post contained an image of pneumocystis carinii pneumonia (PCP) highlighted by a special stain (GMS) and my idea was to have a pathology image per post with a clinical vignette along with it. It […]

Continue Reading

Indica Labs Appoints a Vice President, Pharma Services

| July 31, 2017 | 0 Comments

Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma Services. Mr. Bowman will play an important role as the company develops its image analysis and biomarker assay services business to support preclinical and clinical biomarker assays for Indica Lab’s academic, biotech, and pharma customers. Doug was previously at Takeda Pharmaceuticals for 11 years where […]

Continue Reading

Corista to Host Seminar on Digital Pathology and the Emerging Role of Artificial Intelligence

| July 23, 2017 | 0 Comments

Alexander Baras, M.D., Ph.D. of Johns Hopkins to join company experts at APC presentation Corista, a leader in integrated pathology solutions, is hosting a multi-part seminar on digital pathology and artificial intelligence Tuesday, July 25, during the Association of Pathology Chairs’ Jubilee Meeting in Washington, DC. The seminar features Dr. Alexander Baras from Johns Hopkins […]

Continue Reading

Advisory Board Applauds On-Demand Approach of OptraSCAN

| July 19, 2017 | 0 Comments

OptraSCAN has given tissuepathology.com a rare insight into their advisory board discussions as to what their thought leaders think is important in the digital pathology space for the market. OptraSCAN is of course the first On-Demand digital pathology company that includes a small footprint, high and low throughput WSI scanner OptraSCANTM (that facilitates brightfield, fluorescent and frozen section/live view scanning), […]

Continue Reading

A.I Versus M.D. – Part 2

| July 16, 2017 | 0 Comments

In April I wrote a post entitled A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1. This was followed by a guest post by David West, CEO, Proscia, entitled AI vs MD – What it Means for Pathology in May where David, among many issues points out the use […]

Continue Reading

Kansas Pathology Consultants Adopt Digital Pathology Utilizing ‘On-Demand’ Digital Pathology from OptraSCAN

| July 11, 2017 | 0 Comments

Kansas Pathology Consultants and Services are aiming to go fully digital for remote reporting and consulting of pathology cases, to expedite second opinions and improve overall operational efficiencies SUNNYVALE, CA — OptraSCAN Inc. today announced an agreement with Kansas Pathology Consultants to deliver ‘On-Demand’ Digital Pathology solutions to facilitate remote reporting and consulting opportunities, gearing […]

Continue Reading

Promega Intends to Seek FDA Approval for Microsatellite Instability Assay to Assist in Strategic Cancer Decisions

| July 9, 2017 | 0 Comments

Promega Corporation intends to seek FDA approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. The current Promega Research Use Only MSI Assay has been available and used in the market as part of Lab-Developed Tests since 2004 and is considered the […]

Continue Reading

Will Robot Surgeons Provide Better Clinical Histories?

| July 7, 2017 | 0 Comments

Berci Mesko, MD, PhD, The Medical Futurist, a self-proclaimed “geek physician with a PhD in genomics and Amazon Top 100 author” who envisions “the impact of digital health technologies on the future of healthcare, and helps patients, doctors, government regulators and companies make it a reality” recently shared this infographic on Twitter. Berci has a lot […]

Continue Reading

Digital Pathology Association Session to Take Place at 29th European Congress of Pathology

| July 5, 2017 | 0 Comments

SAVE THE DATE! DIGITAL PATHOLOGY ASSOCIATION SESSION To take place at the 29th European Congress of Pathology Sunday, September 3, 2017 | 2:45-5:15 PM Amsterdam, The Netherlands Presentations Include: Computational Pathology and Interoperability to advance Digital Pathology Esther Abels, MSc Philips Digital Pathology Solutions   Automated IA of Immunohistochemistry as a Biomarker for Immuno-oncology Michael Montalto, PhD Bristol-Myers Squibb […]

Continue Reading

Huron Digital Pathology Breaks Ground on New R&D and Manufacturing Facility

| June 27, 2017 | 0 Comments

As I mentioned in a post earlier this year following a visit to the existing Huron Digital Pathology headquarters in Ontario, Canada, St. Jacobs can now lay claim to not only the best apple fritters in the world but the new home of Huron Digital Pathology! There are a lot of interesting facets to the […]

Continue Reading

Q&A with Philips Digital Pathology

| June 23, 2017 | 0 Comments

I recently had an opportunity to speak with Esther Abels, Director of Regulatory, Clinical and Medical Affairs for Philips Digital Pathology Solutions about Philips’ recent approval to market their Philips Intellisite Pathology System (PIPS) for primary diagnosis of biopsies and excisions in the United States. My thanks to Esther and Philips’ marketing team for their […]

Continue Reading

OptraSCAN Digital Pathology Summer Special

| June 20, 2017 | 0 Comments

Customize your own On-Demand Digital Pathology bundle with a WSI OptraSCANTM Brightfield Scanner and IMAGEPathTM Image Management System for $500/month (with no contract requirements) and $1/per slide scanned. Offer expires July 31st. OptraSCANTM OS15 Brightfield scanner 15-slide scanning capability Cloud-enabled with touchscreen Lightweight and portable IMAGEPathTM Image Management Software  Cloud-enabled image management allows for remote viewing Store, share and manage images and […]

Continue Reading

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

VisionGate Hires Dr. David Wilbur as Medical Director

| June 9, 2017 | 0 Comments

VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from Massachusetts General Hospital (MGH), where he has been a practicing pathologist since 2001. He headed the Cytopathology Unit until 2011, when he took over the […]

Continue Reading